Summary Company Announcement Date: November 22, 2023 FDA Publish Date: November 22, 2023 Product Type: Food & Beverages Reason for Announcement: Recall Reason Description Potential Foodborne Illness, Salmonella Company Name: SOFIA PRODUCE, LLC dba Trufresh Brand Name: Brand Name(s) Malichita, Rudy Product Description: Product Description Cantaloupes Company Announcement For Immediate Release, November 22, 2023 SOFIA…
Crown Jewels Produce Recalls “Malichita / Z Farms” Label of Whole Cantaloupes Because of Possible Health Risk Due to Salmonella
Summary Company Announcement Date: November 22, 2023 FDA Publish Date: November 22, 2023 Product Type: Food & Beverages Foodborne Illness Reason for Announcement: Recall Reason Description Potential Salmonella contamination Company Name: Crown Jewel Produce Company Brand Name: Brand Name(s) Malichita/ Z Farms Product Description: Product Description Cantaloupes Company Announcement Jewel Marketing and Agribusiness LLC. (dba…
CF Dallas, LLC, in Coordination with Sofia Produce, LLC Dba Trufresh, Voluntarily Recalls Select Fresh-Cut Fruit Products Due to Possible Salmonella Contamination
Summary Company Announcement Date: November 22, 2023 FDA Publish Date: November 22, 2023 Product Type: Food & Beverages Reason for Announcement: Recall Reason Description Potential Foodborne Illness, Salmonella Company Name: CF Dallas, LLC Brand Name: Brand Name(s) Seasonal Blend, Melon Trio and more Product Description: Product Description Cantaloupes Company Announcement CF Dallas, LLC is voluntarily…
Bayer Issues Voluntary Recall Nationwide of VITRAKVI® (larotrectinib) Oral Solution 20 mg/mL Due to Presence of Microbial Contamination
Summary Company Announcement Date: November 17, 2023 FDA Publish Date: November 21, 2023 Product Type: Drugs Reason for Announcement: Recall Reason Description Microbial contamination identified as Penicillium brevicompactum Company Name: Bayer Brand Name: Brand Name(s) Product Description: Product Description Vitrakvi® (larotrectinib) Oral Solution 20 mg/mL in 100mL glass bottles Company Announcement FOR IMMEDIATE RELEASE –…
Urgent – Food Recall Because of Potential Undeclared Allergen Due to Mislabel
Summary Company Announcement Date: November 21, 2023 FDA Publish Date: November 22, 2023 Product Type: Food & Beverages Allergens Reason for Announcement: Recall Reason Description Undeclared soy Company Name: Seneca Foods Corporation Brand Name: Brand Name(s) Product Description: Product Description Turkey Gravy Company Announcement As a precautionary measure, Seneca Foods Corporation is announcing a voluntary…
Voluntary Recall of SoClean Equipment Intended for Use with CPAP Devices and Accessories: FDA Safety Communication
Date Issued: November 21, 2023 The U.S. Food and Drug Administration (FDA) is providing additional information about a product recall related to the use of SoClean2 and SoClean3 equipment used to clean, sanitize, or disinfect CPAP devices and accessories. The company’s recall consists of a new User Manual with additional instructions for use and a…
Publix Voluntarily Recalls Private Label Egg Custard Pie That May Contain Coconut Pie
Summary Company Announcement Date: November 21, 2023 FDA Publish Date: November 21, 2023 Product Type: Food & Beverages Allergens Reason for Announcement: Recall Reason Description Undeclared Coconut Company Name: Publix Supermarkets Inc. Brand Name: Brand Name(s) Publix Supermarkets, Inc. Product Description: Product Description Egg Custard Pie Company Announcement LAKELAND, Fla., Nov 17, 2023 – Publix…
Noah’s Wholesale, LLC Issues Voluntary Nationwide Recall of the Rock Due to Presence of Undeclared Sildenafil
Summary Company Announcement Date: October 18, 2023 FDA Publish Date: November 21, 2023 Product Type: Drugs Reason for Announcement: Recall Reason Description Undeclared drug, Sildenafil Company Name: Noah’s Wholesale, LLC Brand Name: Brand Name(s) Noah’s Wholesale, LLC Product Description: Product Description Dietary Supplement with undeclared Sildenafil Company Announcement FOR IMMEDIATE RELEASE – October 18, 2023…
FDA D.I.S.C.O. Burst Edition: FDA approval of Tibsovo (ivosidenib) for patients with relapsed or refractory myelodysplastic syndromes with a susceptible isocitrate dehydrogenase-1 mutation
Podcast Welcome back to the D.I.S.C.O., FDA’s Drug Information Soundcast in Clinical Oncology, Burst Edition, brought to you by FDA’s Division of Drug Information in partnership with FDA’s Oncology Center of Excellence. Today we’ll provide a quick update on a recent FDA cancer drug approval. On October 24, 2023, the FDA approved ivosidenib (brand name…
Do Not Use Cardinal Health Monoject Syringes with Syringe Pumps and PCA Pumps
November 20, 2023 The U.S. Food and Drug Administration (FDA) is alerting health care providers and facilities not to use Cardinal Health Monoject syringes with syringe pumps and patient-controlled analgesia (PCA) pumps while the FDA further evaluates this issue. In June 2023, Cardinal Health began distributing Monoject syringes branded as “Cardinal Health” Monoject syringes. These…